Clinical Trials
28 trialsTQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma
Henan Cancer Hospital
TAS-102 and Anlotinib in ≥3 Lines mGC
Zhejiang University
ALTER-G-001
Ruijin Hospital
FAITH
Shanghai Zhongshan Hospital
Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer
Peking Union Medical College Hospital
Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer
Peking University
ICTCPTLAGC
Xijing Hospital
Phase II Clinical Study of Camrelizumab Combined With Chemotherapy or Anlotinib in Advanced Esophageal Squamous Cell Cancer
Zhejiang Cancer Hospital
ALTER-C003
Peking Union Medical College Hospital
Study of Anlotinib Plus Irinotecan in Patients With Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University
Anlotinib for Esophageal Cancer (AFEC)
Anyang Tumor Hospital
AFHC
People's Hospital of Guangxi Zhuang Autonomous Region
Study of Anlotinib Plus Sintilimab in the Treatment of Advanced Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital
SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer
Peking Union Medical College Hospital
Thermal Ablation Combined With Anlotinib and TQB2450 Solution for HCC
Chinese PLA General Hospital
Tislelizumab Plus Anlotinib for Immunotherapy Resistant Gastrointestinal Cancer
Peking University
Niraparib Combined With Anlotinib in Homologous Recombination Repair (HRR) Gene-mutated Advanced Solid Tumors
Peking University Cancer Hospital & Institute
A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
ALTER-H-002
Shanghai Zhongshan Hospital
Anlotinib in Combination With PD1 With Gemcitabine Plus(+)Cisplatin for Unresectable or Metastatic Biliary Tract Cancer
Zhejiang Cancer Hospital
Anlotinib In Combination With RFA And TACE in Patients With Middle-advanced HCC
Beijing Ditan Hospital
A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Efficacy and Safety of Anlotinib in Patients With Advanced Gastrointestinal Stromal Tumor After Failure of Imatinib: a Prospective, Single Arm and Multicenter Trial
Cttq
TACE Combined With Anlotinib Treatment of Middle-advanced Hepatocellular Carcinoma (HCC) Patients
Zhejiang Cancer Hospital
ATAHC
The First Affiliated Hospital with Nanjing Medical University
A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
ALTER0802
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.